StockStory.org on MSN2h
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals StocksAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Shares of Viatris Inc. VTRS slipped 1.07% to $9.24 Wednesday, on what proved to be an all-around mixed trading session for ...
NEW YORK CITY, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Barclays 27th Annual Global Healthcare Conference Call March 11, 2025 2:00 PM ETCompany ParticipantsScott Smith - Chief ...
The Law Offices of Frank R. Cruz announces an investigation of Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of investors concerning the Company's possible violations of federal ...
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
TipRanks on MSN5d
Viatris price target lowered to $13 from $15 at JefferiesJefferies analyst Glen Santangelo lowered the firm’s price target on Viatris (VTRS) to $13 from $15 and keeps a Buy rating on the shares after ...
The students were the focus of this STEM fair and they showed up ready to present what they learned in a self-designed ...
Viatris emerged from Pfizer's merger with Mylan and Upjohn, trading since 2020, with a market cap of $11 billion. See why I ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback